Over the past 12 months, 3 insiders at Cellectar Biosciences, Inc. filed 3 open-market SEC Form 4 transactions on CLRB: 2 purchases worth $50K and 1 sale worth $733. Insiders have been net buyers over this period. The most recent filing was on May 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 26 | James Caruso VChief Executive Officer | BUY | 8.7K | $2.88 | $25K |
| May 7, 26 | Jarrod LongcorChief Operating Officer | BUY | 8.7K | $2.88 | $25K |
| Dec 12, 25 | John NeisDirector | SELL | 198 | $3.70 | $733 |
| Jul 2, 25 | James Caruso VChief Executive Officer | BUY | 10.0K | $4.99 | $50K |
| Jul 2, 25 | Chad J KoleanChief Financial Officer | BUY | 5.0K | $4.99 | $25K |
| Jul 2, 25 | Jarrod LongcorChief Operating Officer | BUY | 10.0K | $4.99 | $50K |
| Jan 10, 25 | Jarrod LongcorChief Operating Officer | BUY | 30.0K | $0.28 | $8K |
| Sep 14, 21 | Douglas J SwirskyDirector | BUY | 25.0K | $1.04 | $26K |
| Sep 3, 21 | Frederick W DriscollDirector | BUY | 19.4K | $1.04 | $20K |
Over the past 12 months, insiders at Cellectar Biosciences, Inc. filed 2 open-market purchases worth $50K and 1 sale worth $733 on CLRB, which makes them net buyers over the period. The most recent Form 4 was filed on May 7, 26.
The largest recent open-market CLRB insider purchase in our data was $50K by James Caruso V, Chief Executive Officer, filed on Jul 2, 25.
3 different insiders at Cellectar Biosciences, Inc. filed open-market SEC Form 4 transactions on CLRB over the last 12 months.
InsiderTape plots every CLRB insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Cellectar Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →